Patent · US Active

Compositions for treating cystic fibrosis

US8137962B2 · kind B2 · utility

1Cited by

2References

4Claims

0Family size

Assignees

University of Florida Research Foundation, INC. · US
THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Terence Flotte · Holden, US
Jeffrey R. Sirninger · Gainesville, US
William Guggino · Baltimore, US
Liudmila Cebotaru · Baltimore, US
Christian Müller · Reinach, CH

Key dates

Filing date	Mar 2, 2007
Grant date	Mar 20, 2012
Priority date	—
Expiry date	Mar 2, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2799/025
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods of treating cystic fibrosis. More specifically, this invention relates to the use the AAV vectors and constructs to provide gene therapy to cystic fibrosis patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.